PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

导出 OA

翻译打印收藏纠错

作者： Michael,Fraser ^[1] ; Helen,Zhao ; Kaisa R,Luoto ; Cecilia,Lundin ; Carla,Coackley ; Norman,Chan ; Anthony M,Joshua ; Tarek A,Bismar ; Andrew,Evans ; Thomas,Helleday ; Robert G,Bristow

作者单位： Ontario Cancer Institute/Princess Margaret Hospital (University Health Network), University of Toronto, Toronto, Canada. ^[1]

主题词动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);DNA损伤(DNA Damage);DNA结合蛋白质类(DNA-Binding Proteins);酶抑制剂(Enzyme Inhibitors);基因缺失(Gene Deletion);基因表达(Gene Expression);基因沉默(Gene Silencing);人类(Humans);男(雄)性(Male);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);PTEN磷酸水解酶(PTEN Phosphohydrolase);前列腺肿瘤(Prostatic Neoplasms);Rad51重组酶(Rad51 Recombinase);紫外线(Ultraviolet Rays)

DOI 10.1158/1078-0432.CCR-11-2189

PMID 22114138

发布时间 2022-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览38

Clinical cancer research

2012年18卷4期

1015-27页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除